Due to the prodigious response to our press release regarding the Prostate Screening EpiSwitch® (PSE), we wanted to give everyone a quick update. Currently, the PSE is not commercially available, and no clinical trials are underway. We are working hard to bring this important test into the clinical lab for routine diagnostic testing. For more information regarding the PSE, please check out our press release and published article in Cancers. Thank you for being so supportive, and please check our website for future updates on this subject.